FroggaBio’s Post

Checkout the PolyJet™ In Vitro DNA Transfection Reagent by SignaGen Laboratories — available now at 43% OFF during out Black Friday Sale! Formulated with proprietary polymer synthesis technology for efficient and reproducible transfection in mammalian cells. 🐸🧬🔬 LEARN MORE: https://hubs.li/Q02ZPJmD0 The PolyJet™ reagent ensures rapid and complete degradation after endocytosis, minimizing cytotoxicity. It offers high titers of virus production and is suitable for both single and multi-DNA transfection. Explore its broad transfection spectrum today! 🌟 SHOP SALE: https://hubs.li/Q02ZPHNf0 VIEW FLYER: https://hubs.li/Q02ZPJt80 📆 Sale Ends: November 29th, 2024 #PolyJet #DNAtransfection #Biotechnology #MammalianCells #Science #Research #CellCulture #Genetics #TransfectionEfficiency #LabLife #Innovation #FroggaBio #Biodegradable #RecombinantProtein #STEM #PolymerSynthesis #TransfectionProtocol #CellBiology #LifeSciences #LabResearch #PolyJetReagent #SignaGen #LabTech #TransfectionReagent #ScientificDiscovery #Bioengineering #CellularResearch

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure: https://lnkd.in/dYRNscVS The size of global #syntheticbiology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Group Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #synbio #biotechnology #geneticengineering #bioinnovation

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure:-https://lnkd.in/dngpwpy4 The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure:-https://lnkd.in/dCbcuted The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure: https://lnkd.in/dcMCBsVv The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific,  Merck Agilent Technologies  Novozymes  Ginkgo Bioworks, Inc.  Amyris Precigen GenScript Twist Bioscience  Synthetic Genomics Vaccines Inc  Codexis, Inc.  Synthego Corporation  Creative Enzymes  Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio  Cellectis Zymergen  Synthego Corporation  Intrexon Corporation  DNA Script Arbor Biotechnologies  CRISPR Therapeutics  Evolva Synthetic Biology Australasia  Benchling Beam Therapeutics  Joyn Bio  Aether  Eligo Bioscience  Arcturus Therapeutics  Inscripta, Inc. .  Moderna  PlasmidFactory GmbH - The Minicircle Company  Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group  Leaf Expression Systems  Oxford Biomedica  Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure: https://lnkd.in/gPjsY3-r The size of global #syntheticbiology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

DNA sequencing has been crucial in deepening our comprehension of organisms' genetic composition, enabling the diagnosis of genetic disorders, and setting the stage for customized therapies. In a recent conversation with Nava Whiteford, currently working as consultant at 𝗪𝗵𝗶𝘁𝗲𝗳𝗼𝗿𝗱 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗟𝗶𝗺𝗶𝘁𝗲𝗱, we covered key subjects such as the progress of DNA sequencing, its role in personalized medicine, the anticipated advancements in DNA sequencing technology, and the obstacles and strategies for overcoming them. Read more here https://lnkd.in/gnjm6JXD #lbs #lbs24 #londonbiotechnologyshow #biotechnology #innovation #bioinformatics #medtech #agriculture #bioengineering #innovation #lifesciences #bioenergy #genetics

🌐 🗺 Our list of the 14 Must-Attend Genomic and Biotechnology Conferences and Courses for 2024. There is no need to endlessly search, we've researched for you. Take a look here https://lnkd.in/dQWiDCir #ACMG2024, #ESHG2024 #ASHG2024 #LondonCalling2024 #genetics #raredisease

BCBN Feed: Digital Twins of Biological Systems Inform Drug Development https://lnkd.in/gR2zJKPJ Virtualization isn’t limited to industrial processes, such as biomanufacturing, it’s also a way to engage with biological systems—at multiple scales. The post Digital Twins of Biological Systems Inform Drug Development appeared first on GEN - Genetic Engineering and Biotechnology News. ... [...]

A NEW POWERFUL NATURAL DEFENSE Lactive is a synergistic patented product, born from the observation of the extraordinary mechanism with which babies defend themselves from pathogen attacks. From the mother's milk, in fact, the baby, thanks to its natural enzymes, generates these peptides that effectively defend it. 👉 Antiviral Activity 👈 Scientific evidence shows that it is able to prevent viral infections by preventing the virus from entering the host cell. BIBLIOGRAPHY Effects of Lactoferrin and Lactoferricin on the Release of Interleukin 8 from Human Polymorphonuclear. Ichizo Shinoda, Mitsunori Takase, Yasuo Fukuwatari, Seiichi Shimamura, Manfred Köller & Wolfgang König (1996) Leukocytes, Bioscience, Biotechnology, and Biochemistry, 60:3, 521-523, DOI: 10.1271/bbb.60.521 Find out more, Contact us! customerservice_italy@bict.it #lactive #lactoferricin #naturalhealt #naturalpeptide #boostyourproduct #lactoferrin #innovation #biotech #medicaldevice #ingredienteattivo #lattoferricina #antivirale #antibatterico #immunostimolante #microbioma https://lnkd.in/evVgM4KM